Literature DB >> 20130237

The post sepsis-induced expansion and enhanced function of regulatory T cells create an environment to potentiate tumor growth.

Karen A Cavassani1, William F Carson, Ana Paula Moreira, Haitao Wen, Matthew A Schaller, Makoto Ishii, Dennis M Lindell, Yali Dou, Nicholas W Lukacs, Venkateshwar G Keshamouni, Cory M Hogaboam, Steven L Kunkel.   

Abstract

One of the more insidious outcomes of patients who survive severe sepsis is profound immunosuppression. In this study, we addressed the hypothesis that post septic immune defects were due, in part, to the presence and/or expansion of regulatory T cells (Tregs). After recovery from severe sepsis, mice exhibited significantly higher numbers of Tregs, which exerted greater in vitro suppressive activity compared with controls. The expansion of Tregs was not limited to CD25(+) cells, because Foxp3 expression was also detected in CD25(-) cells from post septic mice. This latter group exhibited a significant increase of chromatin remodeling at the Foxp3 promoter, because a marked increase in acetylation at H3K9 was associated with an increase in Foxp3 transcription. Post septic splenic dendritic cells promoted Treg conversion in vitro. Using a solid tumor model to explore the function of Tregs in an in vivo setting, we found post septic mice showed an increase in tumor growth compared with sham-treated mice with a syngeneic tumor model. This observation could mechanistically be related to the ability of post septic Tregs to impair the antitumor response mediated by CD8(+) T cells. Together, these data show that the post septic immune system obstructs tumor immunosurveillance, in part, by augmented Treg expansion and function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20130237      PMCID: PMC2881495          DOI: 10.1182/blood-2009-09-241083

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  49 in total

1.  CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells.

Authors:  E Suri-Payer; A Z Amar; A M Thornton; E M Shevach
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

Review 2.  Chronic allograft failure: the clinical problem.

Authors:  H Nagano; N L Tilney
Journal:  Am J Med Sci       Date:  1997-05       Impact factor: 2.378

3.  A role for CD103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection.

Authors:  Isabelle Suffia; Stacie K Reckling; Gerson Salay; Yasmine Belkaid
Journal:  J Immunol       Date:  2005-05-01       Impact factor: 5.422

4.  Regulatory T cell lineage specification by the forkhead transcription factor foxp3.

Authors:  Jason D Fontenot; Jeffrey P Rasmussen; Luke M Williams; James L Dooley; Andrew G Farr; Alexander Y Rudensky
Journal:  Immunity       Date:  2005-03       Impact factor: 31.745

5.  Reversal of long-term sepsis-induced immunosuppression by dendritic cells.

Authors:  Claudia F Benjamim; Steven K Lundy; Nicholas W Lukacs; Cory M Hogaboam; Steven L Kunkel
Journal:  Blood       Date:  2004-12-16       Impact factor: 22.113

6.  Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo.

Authors:  Mei-Ling Chen; Mikaël J Pittet; Leonid Gorelik; Richard A Flavell; Ralph Weissleder; Harald von Boehmer; Khashayarsha Khazaie
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-27       Impact factor: 11.205

7.  IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense.

Authors:  M L Steinhauser; C M Hogaboam; S L Kunkel; N W Lukacs; R M Strieter; T J Standiford
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

Review 8.  Tumour necrosis factor and cancer.

Authors:  Frances Balkwill
Journal:  Nat Rev Cancer       Date:  2009-04-03       Impact factor: 60.716

9.  Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells.

Authors:  J Wang; L Sun; L Myeroff; X Wang; L E Gentry; J Yang; J Liang; E Zborowska; S Markowitz; J K Willson
Journal:  J Biol Chem       Date:  1995-09-15       Impact factor: 5.157

10.  CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production.

Authors:  A M Thornton; E M Shevach
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307

View more
  58 in total

Review 1.  Epigenetic regulation of immune cell functions during post-septic immunosuppression.

Authors:  William F Carson; Karen A Cavassani; Yali Dou; Steven L Kunkel
Journal:  Epigenetics       Date:  2011-03-01       Impact factor: 4.528

2.  The parallel lives of angiogenesis and immunosuppression: cancer and other tales.

Authors:  Gregory T Motz; George Coukos
Journal:  Nat Rev Immunol       Date:  2011-09-23       Impact factor: 53.106

3.  Class I and II histone deacetylase inhibition by ITF2357 reduces SLE pathogenesis in vivo.

Authors:  Nicole L Regna; Cristen B Chafin; Sarah E Hammond; Abdul G Puthiyaveetil; David L Caudell; Christopher M Reilly
Journal:  Clin Immunol       Date:  2014-01-15       Impact factor: 3.969

4.  Interruption of macrophage-derived IL-27(p28) production by IL-10 during sepsis requires STAT3 but not SOCS3.

Authors:  Markus Bosmann; Norman F Russkamp; Birgit Strobl; Julian Roewe; Liza Balouzian; Florence Pache; Markus P Radsak; Nico van Rooijen; Firas S Zetoune; J Vidya Sarma; Gabriel Núñez; Mathias Müller; Peter J Murray; Peter A Ward
Journal:  J Immunol       Date:  2014-10-27       Impact factor: 5.422

5.  Sepsis-Induced State of Immunoparalysis Is Defined by Diminished CD8 T Cell-Mediated Antitumor Immunity.

Authors:  Derek B Danahy; Samarchith P Kurup; Christina S Winborn; Isaac J Jensen; John T Harty; Thomas S Griffith; Vladimir P Badovinac
Journal:  J Immunol       Date:  2019-06-12       Impact factor: 5.422

6.  The outcome of polymicrobial sepsis is independent of T and B cells.

Authors:  Markus Bosmann; Norman F Russkamp; Vinay R Patel; Firas S Zetoune; J Vidya Sarma; Peter A Ward
Journal:  Shock       Date:  2011-10       Impact factor: 3.454

Review 7.  Sepsis-Induced T Cell Immunoparalysis: The Ins and Outs of Impaired T Cell Immunity.

Authors:  Isaac J Jensen; Frances V Sjaastad; Thomas S Griffith; Vladimir P Badovinac
Journal:  J Immunol       Date:  2018-03-01       Impact factor: 5.422

Review 8.  The inflammatory response in sepsis.

Authors:  Markus Bosmann; Peter A Ward
Journal:  Trends Immunol       Date:  2012-10-02       Impact factor: 16.687

Review 9.  Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.

Authors:  Richard S Hotchkiss; Guillaume Monneret; Didier Payen
Journal:  Nat Rev Immunol       Date:  2013-11-15       Impact factor: 53.106

10.  STAT3-mediated IL-17 production by postseptic T cells exacerbates viral immunopathology of the lung.

Authors:  Sumanta Mukherjee; Ronald M Allen; Nicholas W Lukacs; Steven L Kunkel; William F Carson
Journal:  Shock       Date:  2012-11       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.